Ipamorelin is one of the most selective GHRPs studied and is noted for releasing growth hormone with minimal effect on cortisol or prolactin, which is a key reason it is paired with CJC-1295
Monitor patients receiving hydrocodone bitartrate and acetaminophen tablets and any Cytochrome P450 3A4 inhibitor or inducer for signs of respiratory depression or sedation [see CLINICAL PHARMACOLOGY
The STEP 1 trial showed continued weight reduction through week 68 (approximately 17 months), with a final average loss of 14.9% of starting body weight at 2.4 mg weekly
[DOI] [PMC free article] [PubMed] [Google Scholar] 142.Chen XY, Chen L, Yang W, Xie AM
Dev Neurosci 32:335342 Kochanek PM, Carney N, Adelson PD, Ashwal S, Bell MJ, Bratton S, Carson S, Chesnut RM, Ghajar J, Goldstein B, Grant GA, Kissoon N, Peterson K, Selden NR, Tasker RC, Tong KA, Vavilala MS, Wainwright MS, Warden CR (2012) Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescentssecond edition
This makes it easier to stick to a reduced-calorie diet without feeling deprived or constantly hungry